Castle Creek Biosciences, Inc.的封面图片
Castle Creek Biosciences, Inc.

Castle Creek Biosciences, Inc.

生物技术研究

Exton,Pennsylvania 3,134 位关注者

Dedicated to making life better for people living with genetic diseases

关于我们

Castle Creek Biosciences is a late-stage company developing re-dosable gene therapies. It is preparing to launch a pivotal clinical trial of its lead candidate, D-Fi, for patients with dystrophic epidermolysis bullosa (DEB).

网站
https://castlecreekbio.com
所属行业
生物技术研究
规模
11-50 人
总部
Exton,Pennsylvania
类型
私人持股
创立
2020
领域
Gene therapy、Rare disease、Clinical research、Drug development、Dermatology、Epidermolysis Bullosa、Life sciences、Personalized medicine、Biotechnology、Genetics、Orphan drug、Pediatric disease和Bioscience

地点

  • 主要

    405 Eagleview Blvd

    US,Pennsylvania,Exton,19341

    获取路线

Castle Creek Biosciences, Inc.员工

动态

相似主页

查看职位

融资